Efficacy of Auricular Vagus Nerve Stimulation

Not Applicable

Recruiting

• Conditions: Being Diagnosed With Frozen Shoulder by a Specialist Physician; Volunteer to Participate in the Study; Being in the 18-50 Age Population

• Registration Number: NCT05586412
• Lead Sponsor: Inonu University

Brief Summary

Auricular Vagus Nerve Stimulation, a non-invasive method, will be used in the study. Studies have shown that vagus nerve stimulation combined with a large vagal nerve network can have a neuromodulatory effect that will activate some natural protective pathways to improve health. Clinically, vagus nerve stimulation is FDA-approved for epilepsy, treatment-resistant depression, and morbid obesity. Since OSS dysfunction is also involved in the etiology of DO and there is no study on the effectiveness of vagus nerve stimulation in this disease, this study is planned to reveal the effectiveness of auricular vagus nerve stimulation and home exercise program in DO patients.

Detailed Description

The shoulder junction is a very dynamic structure that has a wide arc of motion and can move in sagittal, vertical and transverse planes, and provides the connection between the trunk and the upper extremity. Due to this dynamic structure, the shoulder junction is a joint where soft tissue pathologies are common. One of the most common of these pathologies is adhesive capsulitis or frozen shoulder (DO). DO has been defined by different names and with some minor differences in the literature for over 100 years. It has been defined by various names such as adherent obliterative bursitis, adhesive bursitis, periarticular fibrositis, scapulohumeral periarthritis, Duplay periarthritis, adhesive capsulitis. DO was first defined as "scapulohumeral periarthritis" in 1896 by Duplay. In 1934, Codman used the term "frozen shoulder" and suggested that it is seen together with rotator cuff tendinitis. The most widely accepted is the definition made by Neviaser in 1945. It is a disease picture characterized by pain and limitation of movement in the shoulder joint, which is defined as inflammation in the capsule and synovium first, followed by adhesion formations, especially in the axillary fold and the attachment of the capsule to the anatomical neck of the humerus.

Although the exact mechanism of action of vagus nerve stimulation is not known, studies on humans have shown that it affects many areas of the brain at the subcortical and cortical level. A high peripheral sympathetic tone causes regional ischemia, which causes widespread pain. Therapeutic interventions that result in vasodilation (eg, exercise) and appropriate autonomic changes have proven to be effective on pain. The vagus nerve, the "great perfect protector" of the body, encompasses a complex neuro-endocrine-immune network that maintains homeostasis. With reciprocal neural connections to multiple areas of the brain, the vagus nerve serves as a control center that integrates sensitive information and provides appropriate feedback responses. Recent studies show that the vagus nerve is involved in inflammation, mood and pain regulation. All of these can be modulated with vagus nerve stimulation. Vagus nerve stimulation, together with an extensive vagal nerve network, can exert a neuromodulatory effect that will activate some natural protective pathways for health restoration.

Recent preclinical studies show that vagus nerve stimulation is very potent and effective in modulating pain in humans. A medical device allowed the auricular branch of the vagus nerve to be stimulated without any surgery. As a result, it was found that the pain threshold increased and the mechanical pain sensitivity decreased. As a result of the studies, there is a possibility that Frozen Shoulder is a disease that occurs with OSS disorder. Vagus nerve stimulation can be used as an adjunct therapy to correct OSS disorder. Since there is no study in the literature on vagus nerve stimulation in Frozen Shoulder, such a study was considered.

Study Timeline

• Study Start: 2022-07-07
• Study First Submitted: 2022-08-16
• Status Verified: 2022-10
• Study First Submitted QC: 2022-10-17
• Last Update Submitted: 2022-10-17
• Study First Posted: 2022-10-19
• Last Update Posted: 2022-10-19
• Primary Completion: 2022-11-03
• Study Completion: 2022-12-20

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• To be in the 18-50 age population, to be diagnosed with Frozen Shoulder by a specialist physician

Exclusion Criteria

• Patients with neurological deficits, neuropathic disorders, chronic inflammation, other musculoskeletal disorders in the upper extremities, pregnant women, and patients who had additional changes in their current treatment other than vagus nerve stimulation were excluded from the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
kinesiophobia assessment	6 months	Tampa Kinesiophobia Scale were used. The Tampa Kinesiophobia Scale (TKS) is one of them, and it's commonly used in the literature to assess kinesiophobia. It has 17 questions designed to assess fear of moving.
Pain Assessment	6 months	Pain Assessment Visual Analogue Scale (VAS) was used. On a 10-centimeter (cm) horizontal line, start 0 (no pain) and finish 10 (unbearable pain) are marked and the subjects were asked to place a mark on this horizontal line according to the degree of pain they felt. The point marked on the line was then measured with the help of a ruler and recorded as the VAS value in cm.
Shoulder Pain and Disability Assessment	6 months	The Shoulder Pain and Disability Index, developed by Roach et al. in 1911, was used to assess the level of disability by questioning the level of limitation experienced by the participants during personal carrying, care and dressing activities, and to measure current shoulder pain and disability. The Spadi scale consists of 2 subscales of pain (5 questions) and disability (8 questions) and 13 subheadings. Pain and disability subscales are calculated between 0 (no pain) - 100 (worst pain imaginable). As a result of the survey, 3 different scores are obtained as Obstacle, Pain and Total score, each of which is scored separately. The answers given to the questions in the scale are calculated as the last percentile. The higher the total score on the scale, the higher the person's level of pain or disability.
Depression Assessment	6 months	Depression Severity Assessment, The Beck Depression Inventory (BDI) was employed, which consists of 21 questions. The scale has a range of 0 to 84 points.
joint range of motion assessment	6 months	ROM will be evaluated with the goniometric measurement. This measurement method is an objective method used in the clinical evaluation of joint range of motion. Shoulder flexion, extension, abduction, adduction, external and internal rotation movements of the patients will be measured 3 times passively and actively with a universal goniometer.
functional limitation and disability status assessment	6 months	In our study, the Arm, Shoulder and Hand Problems Questionnaire (DASH), which is more preferred in the clinic, was used to evaluate upper extremity functional limitation and disability, which consists of 3 parts. The questionnaire consists of 30 questions that determine the function score in the first part; 21 questions about difficulty in activities of daily living, 5 questions about symptoms (pain, tingling, stiffness, activity-related pain), each of the remaining questions evaluates the patient's social function, work, sleep and self-confidence. The second part of the questionnaire is answered optionally and is a business model consisting of 4 questions. In the third part of the questionnaire, there is a section consisting of 4 elective questions that determine the disability level of patients who are sports-musician models, who want high performance, who are involved in sports or music.
Quality of Life assessment	6 months	In our study, the widely preferred SF-36 form, consisting of 36 items, was used to evaluate the quality of life in patients with musculoskeletal disorders, whose reliability and validity have been demonstrated by studies. The 36 items in this form cover 8 different health-related dimensions: physical, emotional and social function, physical role, mental health, general health, pain and vitality. For these dimensions, the scores of the items are coded and converted into a scale between 0-100 points. The scale that evaluates the scores of each subgroup between 0-100; 0 indicates "worst health" status, 100 indicates "best health" status.

Trial Locations

Locations (1)

Malatya Sevgi Hospital; 🇹🇷 Malatya, Battalgazi̇, Turkey